Investigational CAR T-Cell Therapy Zola-Cel Under Scrutiny Following Fatal Event in MS Trial on October 24, 2026 Posted by
The Silent Surge: Why Strokes Are Targeting Younger Adults at Alarming Rates on October 24, 2026 Posted by
Bridging the Gap: ERS Joins Global Coalition to Champion Scientific Integrity and Public Health on October 24, 2026 Posted by
The Evolution of Hope: Understanding the Significance of National Recovery Month on October 24, 2026 Posted by
Bridging the Gap: New Bipartisan Legislative Push Targets Substance Use Recovery and Treatment Infrastructure on October 24, 2026 Posted by
The Future of Healing: CRI’s 2026 Gala Spotlights the "Next is Now" Era of Immunotherapy on October 24, 2026 Posted by
The Invisible Obstacle: How Fluid Viscosity Fuels Glioblastoma Aggression on October 24, 2026 Posted by
Investigational CAR T-Cell Therapy Zola-Cel Under Scrutiny Following Fatal Event in MS Trial on October 24, 2026 Posted by
The Silent Surge: Why Strokes Are Targeting Younger Adults at Alarming Rates on October 24, 2026 Posted by
Bridging the Gap: ERS Joins Global Coalition to Champion Scientific Integrity and Public Health on October 24, 2026 Posted by
The Evolution of Hope: Understanding the Significance of National Recovery Month on October 24, 2026 Posted by
Posted in Cancer Recovery A Legacy of Discovery: The Rudensky Symposium and the Future of Immunotherapy on September 25, 2026
Posted in Chronic Disease Management Defying Uncertainty: How the Cancer Research Institute is Redefining the Future of Immunotherapy on September 25, 2026
Posted in Cancer Recovery Breaking the Cycle of Resistance: New Experimental Drug CS18 Targets Cancer’s ‘Biological Switchboard’ on September 25, 2026
Posted in Cancer Recovery Breaking the Cycle of Resistance: New Experimental Drug CS18 Targets Cancer’s ‘Biological Switchboard’ on September 25, 2026
Posted in Cancer Recovery Defying Uncertainty: How the Cancer Research Institute is Safeguarding the Future of Immunotherapy on September 25, 2026
Posted in Chronic Disease Management Defying Uncertainty: How the Cancer Research Institute is Redefining the Future of Immunotherapy on September 25, 2026
Posted in Cancer Recovery Breaking the Shield: Baylor Researchers Develop Experimental Drug CS18 to Neutralize Cancer’s Resistance Mechanisms on September 25, 2026
Posted in Cancer Recovery A Legacy of Discovery: The Rudensky Symposium and the Future of Immunotherapy on September 25, 2026
Posted in Chronic Disease Management Bridging the Gap: How the Cancer Research Institute is Defying Uncertainty to Accelerate Immunotherapy on September 25, 2026
Posted in Cancer Recovery Breaking the Barrier: Baylor Researchers Develop Experimental Drug to Overcome Cancer Therapy Resistance on September 25, 2026
